Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 9, Pages 4526
Publisher
MDPI AG
Online
2021-04-27
DOI
10.3390/ijms22094526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
- (2021) Ebenezer Tumban Viruses-Basel
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
- (2021) Daniele Focosi et al. Life-Basel
- Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?
- (2021) Søren Dinesen Østergaard et al. LANCET
- Covid-19: variants and vaccination
- (2021) Alistair C Darby et al. BMJ-British Medical Journal
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
- (2020) Yanan Cao et al. Cell Discovery
- Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- (2020) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- A hypothesis for pathobiology and treatment of COVID‐19 : The centrality of ACE1 / ACE2 imbalance
- (2020) Krishna Sriram et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
- (2020) Jean-Laurent Casanova et al. CELL
- Angiotensin Converting Enzyme 2: A Double-Edged Sword
- (2020) Kaiming Wang et al. CIRCULATION
- COVID-19 and Cardiovascular Disease
- (2020) Kevin J. Clerkin et al. CIRCULATION
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract
- (2020) Joan C. Smith et al. DEVELOPMENTAL CELL
- Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19
- (2020) Gavin Y Oudit et al. EUROPEAN HEART JOURNAL
- COVID-19 and Smoking. Is Nicotine the Hidden Link?
- (2020) Patrizia Russo et al. EUROPEAN RESPIRATORY JOURNAL
- Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
- (2020) Sandro La Vignera et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COVID‐19 and Renin‐Angiotensin system inhibition – role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy?
- (2020) Aneta Aleksova et al. JOURNAL OF INTERNAL MEDICINE
- Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
- (2020) Hao Cheng et al. JOURNAL OF MEDICAL VIROLOGY
- ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
- (2020) Christian A. Devaux et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 and smoking: A systematic review of the evidence
- (2020) Constantine Vardavas et al. Tobacco Induced Diseases
- Debate on Drugs That May Aggravate COVID-19
- (2020) Pedro Giavina-Bianchi et al. Journal of Allergy and Clinical Immunology-In Practice
- Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation
- (2020) Jiawei Chen et al. AGING CELL
- Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2
- (2020) Yu Zhao et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- COVID-19 Y TABAQUISMO: REVISIÓN SISTEMÁTICA Y METAANÁLISIS DE LA EVIDENCIA
- (2020) Carlos A. Jiménez-Ruiz et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Circulating plasma angiotensin-converting enzyme 2 concentration is elevated in patients with kidney disease and diabetes
- (2020) Iziah E Sama et al. EUROPEAN HEART JOURNAL
- SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart
- (2020) Bishnu P. Dhakal et al. Heart Lung and Circulation
- The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
- (2020) Weiyi Tan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID‐19/SARS‐CoV‐2
- (2020) Yunjin Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2)
- (2020) Owen Wiese et al. JOURNAL OF CLINICAL PATHOLOGY
- COVID-19 and the Immune System
- (2020) J PACES et al. PHYSIOLOGICAL RESEARCH
- Host polymorphisms may impact SARS-CoV-2 infectivity
- (2020) Patrick Brest et al. TRENDS IN GENETICS
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- Association between renin–angiotensin system inhibitors and COVID-19 complications
- (2020) Sophie Liabeuf et al. European Heart Journal-Cardiovascular Pharmacotherapy
- SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
- (2020) Denisa Bojkova et al. CARDIOVASCULAR RESEARCH
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
- (2020) Gianluca Trifirò et al. DRUG SAFETY
- Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study
- (2020) Cristina Basso et al. EUROPEAN HEART JOURNAL
- Autopsy findings in COVID-19-related deaths: a literature review
- (2020) Aniello Maiese et al. Forensic Science Medicine and Pathology
- Gene of the month: TMPRSS2 (transmembrane serine protease 2)
- (2020) Michelle Thunders et al. JOURNAL OF CLINICAL PATHOLOGY
- Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities
- (2020) Laura Falasca et al. JOURNAL OF INFECTIOUS DISEASES
- Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes
- (2020) Emma L. Robinson et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection
- (2020) R.P. Vivek-Ananth et al. MOLECULES
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
- (2020) Donato Zipeto et al. Frontiers in Immunology
- Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
- (2020) Jingwei Bian et al. Acta Pharmaceutica Sinica B
- Peptide and peptide-based inhibitors of SARS-CoV-2 entry
- (2020) Desiree Schütz et al. ADVANCED DRUG DELIVERY REVIEWS
- Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones
- (2020) Anissa Viveiros et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Determinants of soluble angiotensin-converting enzyme 2 concentrations in adult patients with complex congenital heart disease
- (2020) Tanja Raedle-Hurst et al. Clinical Research in Cardiology
- Association between renin–angiotensin–aldosterone system inhibitor use and COVID‐19 hospitalization and death: a 1.4 million patient nationwide registry analysis
- (2020) Gianluigi Savarese et al. EUROPEAN JOURNAL OF HEART FAILURE
- Renin–angiotensin system inhibitors and mortality in patients with COVID-19
- (2020) Luca Rossi et al. INFECTION
- Effects of renin‐angiotensin‐aldosterone system inhibitors on disease severity and mortality in patients with COVID‐19: A meta‐analysis
- (2020) Guoyue Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease
- (2020) HariOm Singh et al. MICROBIAL PATHOGENESIS
- Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
- (2020) Jordan R. Barrett et al. NATURE MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry
- (2020) Georgia Ragia et al. PHARMACOGENOMICS
- SARS-CoV-2, ACE2 expression, and systemic organ invasion
- (2020) Usman M Ashraf et al. PHYSIOLOGICAL GENOMICS
- Adverse impact of renin–angiotensin system blockade on the clinical course in hospitalized patients with severe COVID-19: a retrospective cohort study
- (2020) Jeong-Hoon Lim et al. Scientific Reports
- Coronavirus vaccine? Join the queue
- (2020) The Lancet Diabetes & Endocrinology Lancet Diabetes & Endocrinology
- ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors
- (2020) Zofia Wicik et al. Journal of Clinical Medicine
- Interrelations between COVID-19 and other disorders
- (2020) Amin Gasmi et al. CLINICAL IMMUNOLOGY
- The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients
- (2020) Hao Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19
- (2020) Sarita Choudhary et al. Annals of Laboratory Medicine
- A Disintegrin and Metalloproteases (ADAMs) in Cardiovascular, Metabolic and Inflammatory Diseases: Aspects for Theranostic Approaches
- (2018) Emiel van der Vorst et al. THROMBOSIS AND HAEMOSTASIS
- Nicotine and the Renin-Angiotensin System
- (2018) Joshua M. Oakes et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion
- (2017) Alexandra C. Walls et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sex differences in the aging pattern of renin–angiotensin system serum peptidases
- (2017) A. Fernández-Atucha et al. Biology of Sex Differences
- Present Yourself! By MHC Class I and MHC Class II Molecules
- (2016) Kenneth L. Rock et al. TRENDS IN IMMUNOLOGY
- From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
- (2014) Sheila K. Patel et al. Frontiers in Physiology
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
- (2013) A. Heurich et al. JOURNAL OF VIROLOGY
- Angiotensin Converting Enzyme 2 Contributes to Sex Differences in the Development of Obesity Hypertension in C57BL/6 Mice
- (2012) Manisha Gupte et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- ADAM-17: the enzyme that does it all
- (2010) Monika Gooz CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure
- (2008) Slava Epelman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started